Literature DB >> 1780345

Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine.

A R Caggiula1, L H Epstein, S M Antelman, S S Saylor, K A Perkins, S Knopf, R Stiller.   

Abstract

We have shown that tolerance to the behavioral effects of nicotine is partially dependent on conditioned environmental cues that predict drug delivery. The present research extends this finding to physiological effects of nicotine by assessing both the appetite-suppressing and adrenocortical-activating effects of nicotine, as measured by plasma corticosterone (CORT). In the first study, male rats on a 22-h food deprivation schedule were injected daily with 0.33 or 0.66 mg/kg (free base) of nicotine bitartrate or saline in a distinctive environment and tested for milk intake. Nicotine initially suppressed milk intake and tolerance developed over 10 days. Changing cues associated with drug administration partially reversed tolerance since injection of nicotine in a new environment reduced milk intake of tolerant animals. Similarly, animals who repeatedly received nicotine in one environment exhibited CORT levels lower than rats injected for the first time, and this tolerance also was partially reversed when administration occurred in the new environment. The second experiment indicated that the increased CORT of Experiment 1 was not a stress response associated with injecting animals in a different environment. These results indicate that tolerance to both behavioral and neuroendocrine effects of nicotine is influenced by conditioning.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1780345     DOI: 10.1016/0091-3057(91)90319-w

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  20 in total

1.  Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors.

Authors:  M Zoli; M R Picciotto; R Ferrari; D Cocchi; J P Changeux
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  Acquisition and extinction of conditioned nicotine analgesic tolerance.

Authors:  Julian L Azorlosa; Carolyn E Johnson; James J McConnell
Journal:  Learn Behav       Date:  2006-08       Impact factor: 1.986

3.  Tolerance to nicotine in mice lacking alpha7 nicotinic receptors.

Authors:  C Naylor; D Quarta; C Fernandes; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2005-02-19       Impact factor: 4.530

4.  Plasma corticosterone in the rat in response to nicotine and saline injections in a context previously paired or unpaired with nicotine.

Authors:  Kristina W Davis; Antonio Cepeda-Benito; James H Harraid; Paul J Wellman
Journal:  Psychopharmacology (Berl)       Date:  2005-02-19       Impact factor: 4.530

5.  The role of conditioning history and reinforcer strength in the reinforcement enhancing effects of nicotine in rats.

Authors:  Matthew I Palmatier; Laura C O'Brien; Melanie J Hall
Journal:  Psychopharmacology (Berl)       Date:  2011-08-23       Impact factor: 4.530

6.  Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine.

Authors:  M E Benwell; D J Balfour; L F Khadra
Journal:  Clin Investig       Date:  1994-02

7.  High-fat diet meal patterns during and after continuous nicotine treatment in male rats.

Authors:  Ian A Mendez; Luis Carcoba; Paul J Wellman; Antonio Cepeda-Benito
Journal:  Exp Clin Psychopharmacol       Date:  2016-09-19       Impact factor: 3.157

8.  Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.

Authors:  M Shoaib; M E Benwell; M T Akbar; I P Stolerman; D J Balfour
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

9.  Self-Administered Nicotine Suppresses Body Weight Gain Independent of Food Intake in Male Rats.

Authors:  Laura E Rupprecht; Tracy T Smith; Eric C Donny; Alan F Sved
Journal:  Nicotine Tob Res       Date:  2016-05-18       Impact factor: 4.244

Review 10.  Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system.

Authors:  William M Doyon; Alyse M Thomas; Alexey Ostroumov; Yu Dong; John A Dani
Journal:  Biochem Pharmacol       Date:  2013-07-19       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.